Printer Friendly
The Free Library
23,416,918 articles and books


Cord Blood America Acquires CureSource Assets, Umbilical Cord Blood Storage Company Headquartered in South Carolina.

LOS ANGELES and CHARLESTON, S.C., Aug. 21 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells to families in all 50 states and internationally, today announced that it has acquired the assets of CureSource, Inc., a private umbilical cord blood storage company headquartered in Charleston, South Carolina.

"This is our third acquisition as we continue to grow Cord Blood America into a major umbilical cord blood storage company worldwide," said Matthew Schissler, Chairman and CEO. Details of the transaction were not made public. CureSource(TM), founded in 2003, is known for offering affordable service and for the careful attention it provides families storing their umbilical cords for possible future medical use.

CureSource(TM) currently serves families throughout the U.S. "We are pleased with this transaction because Cord Blood America believes, as we do, in affordable service and taking care of the needs of the families," said CureSource Chairman Donald P. DeLuca, Sr.

"The CureSource transaction provides us with additional customers, and with a new territory to broaden the sales channels that the CureSource staff vigorously developed. This transaction extends Cord Blood America's geographic reach and ensures that we are one of the companies coming out on top as the industry consolidates," Mr. Schissler said. "We view this as another major positive for our Company and our investors."

About Cord Blood America

Cord Blood America (BULLETIN BOARD: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
 CONTACT:
 Paul Knopick
 E & E Communications
 949/707-5365
 pknopick@eandecommunications.com



CONTACT: Paul Knopick of E & E Communications, +1-949-707-5365, pknopick@eandecommunications.com, for Cord Blood America, Inc.

Web site: http://www.corcell.com/ http://www.cordblood-america.com/
COPYRIGHT 2007 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 21, 2007
Words:543
Previous Article:Nick Music and Columbia Records Get Ready to Rock with The Naked Brothers Band Debut Album Featuring Original Soundtrack Music From the Hit...
Next Article:KooKoo Bear Kids' Fabulous Early Fall 2007 Catalog Packed With Designer Rooms and Back to School Items.



Related Articles
Cord Blood America Completes CorCell Acquisition.
Cord Blood America CEO Matthew Schissler Featured on National Business Radio.
Cord Blood America CEO Matthew Schissler in Internet Interview Praises Company's Strong Financial Performance.
Cord Blood America Supports Trend From New York, California for States to Inform Parents of the Advantages of Umbilical Cord Blood Storage.
Cord Blood America Reports $5.8 Million In Revenues In 2007, Up 74 Percent.
Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase.
Cord Blood America CEO Announces Statement Regarding Expansion and Company Valuation.
Cord Blood America Celebrates Sixth Anniversary; Has Grown to One of the Largest Stem Cell Companies in Its Sector.
Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters